| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Salmonella (group B) |
2 |
4 |
≤0.5 － >64 |
Zosyn  |
412 |
| Salmonella (group C) |
0.03 |
0.06 |
≤0.03 － 2 |
Gatifloxacin (Tequin) |
412 |
| Salmonella (group C) |
≤0.12 |
≤0.12 |
≤0.12 － 2 |
Cefepime (Maxipime) |
412 |
| Salmonella (group C) |
0.12 |
0.25 |
≤0.12 － >16 |
Aztreonam (Azactam) |
412 |
| Salmonella (group C) |
≤0.25 |
≤0.25 |
≤0.25 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
| Salmonella (group C) |
≤0.25 |
≤0.25 |
≤0.25 － 32 |
Ceftriaxone (Rocephin) |
412 |
| Salmonella (group C) |
≤0.5 |
≤0.5 |
≤0.5 － 2 |
Imipenem |
412 |
| Salmonella (group C) |
2 |
2 |
≤0.25 － 16 |
Amikacin (Amikin) |
412 |
| Salmonella (group C) |
≤2 |
≤2 |
≤2 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
| Salmonella (group C) |
≤2 |
≤2 |
≤2 － >16 |
Gentamicin (Gentamycin, Garamycin) |
412 |
| Salmonella (group C) |
2 |
4 |
≤0.5 － >64 |
Zosyn |
412 |
| Salmonella (group D) |
0.03 |
0.06 |
≤0.03 － 2 |
Gatifloxacin (Tequin) |
412 |
| Salmonella (group D) |
≤0.12 |
≤0.12 |
≤0.12 － 2 |
Cefepime (Maxipime) |
412 |
| Salmonella (group D) |
0.12 |
0.25 |
≤0.12 － >16 |
Aztreonam (Azactam) |
412 |
| Salmonella (group D) |
≤0.25 |
≤0.25 |
≤0.25 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
| Salmonella (group D) |
≤0.25 |
≤0.25 |
≤0.25 － 32 |
Ceftriaxone (Rocephin) |
412 |
| Salmonella (group D) |
≤0.5 |
≤0.5 |
≤0.5 － 2 |
Imipenem |
412 |
| Salmonella (group D) |
2 |
2 |
≤0.25 － 16 |
Amikacin (Amikin) |
412 |
| Salmonella (group D) |
≤2 |
≤2 |
≤2 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
| Salmonella (group D) |
≤2 |
≤2 |
≤2 － >16 |
Gentamicin (Gentamycin, Garamycin) |
412 |
| Salmonella (group D) |
2 |
4 |
≤0.5 － >64 |
Zosyn |
412 |